🎁 Black Friday: up to 50% off of annual plans
Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.250
+0.010 (0.81%)
Nov 20, 2026, 4:00 PM EST - Market closed

Neuronetics Statistics

Total Valuation

Neuronetics has a market cap or net worth of $120.60 million. The enterprise value is $186.22 million.

Market Cap120.60M
Enterprise Value 186.22M

Important Dates

The last earnings date was Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

Neuronetics has 96.48 million shares outstanding. The number of shares has increased by 24.31% in one year.

Current Share Class 96.48M
Shares Outstanding 96.48M
Shares Change (YoY) +24.31%
Shares Change (QoQ) +5.30%
Owned by Insiders (%) 7.32%
Owned by Institutions (%) 23.76%
Float 40.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.75
Forward PS 0.70
PB Ratio 5.19
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.17
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 3.92.

Current Ratio 2.01
Quick Ratio 1.37
Debt / Equity 3.92
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.65

Financial Efficiency

Return on equity (ROE) is -85.58% and return on invested capital (ROIC) is -7.86%.

Return on Equity (ROE) -85.58%
Return on Assets (ROA) -16.64%
Return on Invested Capital (ROIC) -7.86%
Return on Capital Employed (ROCE) -13.89%
Weighted Average Cost of Capital (WACC) 10.02%
Revenue Per Employee $242,798
Profits Per Employee -$35,074
Employee Count658
Asset Turnover 1.15
Inventory Turnover 16.92

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -16.11% in the last 52 weeks. The beta is 1.32, so Neuronetics's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change -16.11%
50-Day Moving Average 2.18
200-Day Moving Average 1.86
Relative Strength Index (RSI) 30.29
Average Volume (20 Days) 3,450,564

Short Selling Information

The latest short interest is 6.66 million, so 6.90% of the outstanding shares have been sold short.

Short Interest 6.66M
Short Previous Month 7.21M
Short % of Shares Out 6.90%
Short % of Float 16.51%
Short Ratio (days to cover) 9.24

Income Statement

In the last 12 months, Neuronetics had revenue of $159.76 million and -$23.08 million in losses. Loss per share was -$0.32.

Revenue159.76M
Gross Profit 81.37M
Operating Income -14.60M
Pretax Income -23.01M
Net Income -23.08M
EBITDA -11.68M
EBIT -14.60M
Loss Per Share -$0.32
Full Income Statement

Balance Sheet

The company has $22.11 million in cash and $87.73 million in debt, with a net cash position of -$65.62 million or -$0.68 per share.

Cash & Cash Equivalents 22.11M
Total Debt 87.73M
Net Cash -65.62M
Net Cash Per Share -$0.68
Equity (Book Value) 22.40M
Book Value Per Share 0.24
Working Capital 27.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.28 million and capital expenditures -$1.30 million, giving a free cash flow of -$9.58 million.

Operating Cash Flow -8.28M
Capital Expenditures -1.30M
Depreciation & Amortization 2.92M
Net Borrowing -5.63M
Free Cash Flow -9.58M
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross margin is 50.93%, with operating and profit margins of -9.14% and -14.45%.

Gross Margin 50.93%
Operating Margin -9.14%
Pretax Margin -14.40%
Profit Margin -14.45%
EBITDA Margin -7.31%
EBIT Margin -9.14%
FCF Margin n/a

Dividends & Yields

Neuronetics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -24.31%
Shareholder Yield -24.31%
Earnings Yield -25.59%
FCF Yield -7.95%

Analyst Forecast

The average price target for Neuronetics is $6.00, which is 380.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 380.00%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 9.03%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Neuronetics has an Altman Z-Score of -3.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.21
Piotroski F-Score 3